Generic medicine

Erythromycin ethylsuccinate + Sulfisoxazole acetyl

Erythromycin ethylsuccinate + Sulfisoxazole acetyl · ATC J01RA · Anti-infectives · Macrolide antibacterials

Data statusRegistration & price fields require source verification.

1brand families

1registered presentations

1companies

1with current prices

Available dosage forms

Choose a form

Tap a form to filter the brand list

Suspension1 product Clear form filter ×

Advertisement · clearly labelled sponsored placement

Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.

Print / Save PDFAll 1 presentations Filtered1 presentations 1 brands · 1 presentations

Brand	Manufacturer	Registered presentations
Eryzol1 presentation	Magns Pharmaceuticals	200 mg + 600 mg/5 mL Powder for oral suspension 1,s (60 ml) 093674 PKR 72.142026-01-13 —

Price movement

Official price changes for Erythromycin ethylsuccinate + Sulfisoxazole acetyl

No change in the official DRAP price is recorded yet for any of the 1 tracked presentations (records from 13 Jan 2026).

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC J01RA

MedInfoBase. (2026). Erythromycin ethylsuccinate + Sulfisoxazole acetyl — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/generic/erythromycin-ethylsuccinate-sulfisoxazole-acetyl/ ATC J01RA.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.